Granules India to acquire 12.5% stake in USpharma

Granules India Ltd on Thursday said its wholly-owned subsidiary Granules Pharmaceuticals Inc. has entered into an agreement to acquire 12.5% stake in US-based drug maker USpharma Inc. but did not disclose the amount.

“This investment will enable Granules to participate in product selection and have right of first refusal to market the select products which are under development by USpharma,” the company said in a statement.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter